Terapet announces international collaboration for Heavy Ion Therapy QA

Terapet SA are proud to announce an international collaboration to develop a world-first device for patient-specific QA in heavy ion therapy (HIT). Terapet will be joined in the collaboration by Korean partners Yonsei Cancer Center and Oncosoft Inc, who together bring vital medical expertise and software innovations to be united with Terapet’s novel nuclear imaging […]

Closing words on PTCOG61 from our CEO : Christina Vallgren

Our first #PTCOG61 ended with a huge accomplishment! An extremely busy yet very successful exhibition. Thank you to everyone who showed your huge interest in our first product, Qualyscan.I would like to thank my fantastic team who has worked so hard to bring our first product to our customers: Raymond Miralbell, Marcus Palm, Ben Brunt, […]